These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1624396)

  • 21. Report: pharmacokinetic and drug interaction studies of pefloxacin with paracetamol (NNAID) in healthy volunteers in Pakistan.
    Gauhar S; Ali SA; Naqvi SB; Shoaib MH
    Pak J Pharm Sci; 2014 Mar; 27(2):389-95. PubMed ID: 24577931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of ketoprofen (NSAID) on the pharmacokinetics of pefloxacin and ofloxacin in healthy volunteers.
    Fillastre JP; Leroy A; Borsa-Lebas F; Etienne I; Gy C; Humbert G
    Drugs Exp Clin Res; 1992; 18(11-12):487-92. PubMed ID: 1308475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Erythromycin and 2'-acetyl erythromycin concentrations in plasma and pelvic tissues after repeated doses of erythromycin acistrate.
    Lehtonen L; Wikberg R; Karhunen M; Kokkonen P; Tuominen R
    Arzneimittelforschung; 1993 Jan; 43(1):53-6. PubMed ID: 8447849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative activities of pefloxacin and ciprofloxacin in the treatment of chronic respiratory tract infections.
    Scaglione F; Scamazzo F; Arcidiacono MM; Cogo R; Monzani GP; Fraschini F
    J Chemother; 1995 Apr; 7(2):140-5. PubMed ID: 7666121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Penetration of cefmenoxime into serum, gynecologic tissues, and heart valves.
    Daschner FD; Petersen EE; Frank U; Hornig D
    Am J Med; 1984 Dec; 77(6A):4-6. PubMed ID: 6097123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Penetration of cefotetan into serum, myometrium, endometrium and salpinges.
    Just HM; Petersen EE; Bassler M; Frank U; Daschner FD
    Chemotherapy; 1984; 30(5):305-7. PubMed ID: 6593163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disposition kinetics and urinary excretion of pefloxacin after intravenous injection in crossbred calves.
    Srivastava AK; Dumka VK; Deol SS
    Vet Res Commun; 2000 Apr; 24(3):189-96. PubMed ID: 10836277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An evaluation of pelvic tissue concentrations after oral administration of enoxacin.
    Bates SA; Elder MG
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():79-85. PubMed ID: 3162905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma and dialysate levels of pefloxacin and its metabolites in CAPD patients with peritonitis.
    Rose TF; Bremner DA; Collins J; Ellis-Pegler R; Isaacs R; Richardson R; Small M
    J Antimicrob Chemother; 1990 Apr; 25(4):657-64. PubMed ID: 2351626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of pefloxacin after repeated intravenous and oral administration (400 mg bid) in young healthy volunteers.
    Frydman AM; Le Roux Y; Lefebvre MA; Djebbar F; Fourtillan JB; Gaillot J
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():65-79. PubMed ID: 3458699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pefloxacin clinical pharmacokinetics.
    Bressolle F; Gonçalves F; Gouby A; Galtier M
    Clin Pharmacokinet; 1994 Dec; 27(6):418-46. PubMed ID: 7882634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma and tissue concentrations of ceforanide and cefazolin in women undergoing hysterectomy.
    Souney PF; Fisher S; Tuomala RE; Polk BF; Simpson C
    Chemotherapy; 1988; 34(3):185-90. PubMed ID: 3416659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distribution of ceftriaxone in the tissues of the female genital system.
    Fraschini F; Zoncada F; Scaglione F; Radaelli U; Miraglia M; Valmaggi P; Falchi M; Ripamonti L
    Int J Clin Pharmacol Res; 1987; 7(6):499-502. PubMed ID: 3440640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pharmacokinetics and therapeutic efficacy of fleroxacin and pefloxacin in a rat abscess model.
    Leibovitz E; Keren G; Shabtai M; Barzilai A; Rubinstein E
    J Antimicrob Chemother; 1989 Sep; 24(3):375-85. PubMed ID: 2509411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Penetration of pefloxacin into human allograft pancreatic juice.
    Malmborg AS; Brattström C; Tydén G
    J Antimicrob Chemother; 1990 Mar; 25(3):393-7. PubMed ID: 2338418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of intravenously administered pefloxacin in the prostate; perspectives for its application in surgical prophylaxis.
    Giannopoulos A; Koratzanis G; Giamarellos-Bourboulis EJ; Stinios I; Chrisofos M; Giannopoulou M; Giamarellou H
    Int J Antimicrob Agents; 2001 Mar; 17(3):221-4. PubMed ID: 11282268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravitreal penetration of oral pefloxacin in humans.
    Oncel M; Peyman GA
    Int Ophthalmol; 1993 Aug; 17(4):217-22. PubMed ID: 8112969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fleroxacin concentrations in myometrium, ovary and fallopian tube.
    Portmann R; Hansz C; Stiglmayer R; Weidekamm E
    J Antimicrob Chemother; 1989 Apr; 23(4):662-4. PubMed ID: 2501273
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical and pharmacokinetic study of pefloxacin in spontaneous ascitic fluid infections].
    Ducroix JP; Hary L; Andrejak M; Smail A; Tondriaux A; Eb F; Baillet J
    Therapie; 1990; 45(6):461-5. PubMed ID: 2080483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Gonzalez JP; Henwood JM
    Drugs; 1989 May; 37(5):628-68. PubMed ID: 2663414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.